Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Dermatitis, Allergic Contact
- Biologics and Blistering
- The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
- Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects
- The Effects of Dupilumab on Allergic Contact Dermatitis
- Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis
- Bioequivalence of Ethylenediamine Dihydrochloride Study
- Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
- Nickel Desensitization Using Topical Therapy
- NI-0801 in Allergic Contact Dermatitis
- Study of Apremilast in Atopic or Contact Dermatitis
- Study of the Intradermal Injection of rHuPH20 or Placebo in Subjects With Nickel Allergic Contact Dermatitis
- Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
- Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
- Quaternium-15, Use Test
- CP-481,715 Nickel Allergy Study.
- Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
- Clinical Evaluation of Bacitracin